AVT Natural Products Ltd
AVT Natural Products Limited is a part of the A.V. Thomas Group. The Company is engaged in the business of manufacturing plant-based extracts and natural ingredients solutions for the food, beverage, animal nutrition and nutraceutical industries of the world. [1]
- Market Cap ₹ 1,018 Cr.
- Current Price ₹ 66.8
- High / Low ₹ 98.2 / 51.0
- Stock P/E 26.7
- Book Value ₹ 32.8
- Dividend Yield 1.20 %
- ROCE 10.8 %
- ROE 7.83 %
- Face Value ₹ 1.00
Pros
- Company has been maintaining a healthy dividend payout of 20.9%
Cons
- The company has delivered a poor sales growth of 6.16% over past five years.
- Company has a low return on equity of 11.8% over last 3 years.
- Working capital days have increased from 233 days to 338 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
271 | 257 | 267 | 307 | 300 | 330 | 385 | 470 | 542 | 582 | 503 | 519 | |
192 | 207 | 227 | 263 | 270 | 289 | 325 | 402 | 439 | 465 | 435 | 465 | |
Operating Profit | 79 | 50 | 41 | 44 | 30 | 41 | 60 | 69 | 103 | 117 | 69 | 54 |
OPM % | 29% | 20% | 15% | 14% | 10% | 12% | 15% | 15% | 19% | 20% | 14% | 10% |
4 | 3 | 1 | 6 | 12 | 4 | 7 | 7 | 9 | 2 | 12 | 17 | |
Interest | 2 | 3 | 1 | 1 | 2 | 4 | 4 | 3 | 3 | 4 | 4 | 6 |
Depreciation | 5 | 6 | 6 | 7 | 7 | 11 | 14 | 15 | 14 | 13 | 14 | 14 |
Profit before tax | 76 | 44 | 35 | 42 | 33 | 30 | 49 | 58 | 94 | 102 | 63 | 52 |
Tax % | 33% | 32% | 33% | 33% | 35% | 30% | 22% | 26% | 25% | 27% | 26% | 26% |
51 | 30 | 23 | 28 | 21 | 21 | 38 | 42 | 71 | 75 | 46 | 38 | |
EPS in Rs | 3.35 | 1.98 | 1.53 | 1.83 | 1.40 | 1.39 | 2.48 | 2.79 | 4.64 | 4.93 | 3.04 | 2.50 |
Dividend Payout % | 22% | 25% | 26% | 22% | 28% | 29% | 24% | 25% | 22% | 20% | 26% | 16% |
Compounded Sales Growth | |
---|---|
10 Years: | 7% |
5 Years: | 6% |
3 Years: | -1% |
TTM: | 3% |
Compounded Profit Growth | |
---|---|
10 Years: | 2% |
5 Years: | 0% |
3 Years: | -19% |
TTM: | -18% |
Stock Price CAGR | |
---|---|
10 Years: | 8% |
5 Years: | 12% |
3 Years: | -10% |
1 Year: | -23% |
Return on Equity | |
---|---|
10 Years: | 12% |
5 Years: | 14% |
3 Years: | 12% |
Last Year: | 8% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 |
Reserves | 158 | 178 | 194 | 220 | 233 | 246 | 273 | 307 | 365 | 425 | 458 | 484 |
0 | 0 | 0 | 0 | 23 | 65 | 25 | 37 | 11 | 15 | 14 | 88 | |
64 | 42 | 37 | 35 | 58 | 49 | 57 | 63 | 55 | 60 | 96 | 129 | |
Total Liabilities | 237 | 236 | 246 | 271 | 329 | 376 | 370 | 422 | 446 | 514 | 583 | 716 |
50 | 53 | 58 | 57 | 56 | 98 | 99 | 89 | 82 | 78 | 80 | 71 | |
CWIP | 0 | 2 | 1 | 0 | 28 | 0 | 0 | 0 | 2 | 0 | 0 | 4 |
Investments | 23 | 16 | 37 | 47 | 40 | 17 | 17 | 24 | 45 | 75 | 148 | 157 |
164 | 166 | 150 | 166 | 205 | 261 | 254 | 309 | 317 | 361 | 354 | 483 | |
Total Assets | 237 | 236 | 246 | 271 | 329 | 376 | 370 | 422 | 446 | 514 | 583 | 716 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
66 | 14 | 38 | 20 | 13 | -27 | 72 | 6 | 69 | 53 | 105 | -53 | |
-22 | -1 | -32 | -10 | -29 | 4 | -14 | -11 | -29 | -37 | -82 | -9 | |
-37 | -14 | -9 | -8 | 14 | 26 | -53 | -1 | -42 | -15 | -19 | 58 | |
Net Cash Flow | 7 | -1 | -3 | 2 | -1 | 2 | 5 | -6 | -1 | 1 | 4 | -4 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 53 | 61 | 64 | 74 | 78 | 80 | 69 | 86 | 71 | 81 | 80 | 103 |
Inventory Days | 267 | 271 | 185 | 178 | 197 | 335 | 232 | 239 | 257 | 299 | 322 | 424 |
Days Payable | 67 | 33 | 22 | 39 | 83 | 69 | 44 | 62 | 48 | 47 | 112 | 152 |
Cash Conversion Cycle | 253 | 299 | 227 | 213 | 192 | 346 | 257 | 263 | 280 | 333 | 291 | 375 |
Working Capital Days | 125 | 167 | 151 | 148 | 159 | 224 | 171 | 187 | 174 | 184 | 179 | 338 |
ROCE % | 47% | 26% | 17% | 18% | 13% | 11% | 16% | 18% | 26% | 25% | 14% | 11% |
Documents
Announcements
-
Annual
30 May - Annual Secretarial Compliance Report filed; minor fine of Rs.25,960 paid for delayed Company Secretary appointment.
- Corporate Action-Board approves Dividend 28 May
-
Board Meeting Outcome for Outcome Of Board Meeting
28 May - Audited FY25 results approved; final 40% dividend declared; new Manager appointed; 39th AGM on Aug 13, 2025.
-
Board Meeting Intimation for Approval Of Audited Financial Results For Quarter And Year Ended 31.03.2025 And Consider And Recommend The Final Dividend, If Any
20 May - Board meeting on May 28 to approve FY25 audited results and consider final dividend.
-
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
29 Apr - Company confirms it is not a Large Corporate as per SEBI fund raising circulars.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from nse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Products Segments: The company operates in the business segment of Food & Feed Ingredients from Natural Raw materials. [1]